Top Rapid Plasma Reagin Test Companies

Rapid plasma reagin test providers should focus on raising more awareness regarding syphilis and STI testing to boost their business scope. Investing in the R&D of novel portable and rapid tests is also a prominent opportunity for companies as per this global rapid plasma reagin test market analysis.

Reducing the test and result times for novel rapid plasma reagin tests is slated to generate new opportunities for market players. Here’s a startup that has the potential to augment the rapid plasma reagin test industry in the long run.

• Mylab Discovery Solutions: Based in Pune, Maharashtra, India the startup has developed rapid diagnostic kits for the early detection of sexually transmitted infections, including syphilis. The 2016-founded company’s Syphilis Antibody test detects antibodies (IgG, IgA, IgM) to Treponema pallidum, facilitating early diagnosis. These tests are designed for ease of use, can be stored at room temperature, and are deployable at the point of care, making them suitable for resource-limited settings.

Top Player’s Company Profiles

• Quotient Limited (Switzerland)

• CareDx Inc. (U.S.)

• Agena Bioscience, Inc. (Mesa Laboratories, Inc.) (U.S.)

• DIAGAST (U.S.)

• Illumina, Inc. (U.S.)

• Grifols, S.A. (Spain)

• Immucor, Inc. (U.S.)

• Bio-Rad Laboratories, Inc. (U.S.)

• Thermo Fisher Scientific Inc. (U.S.)

• Merck KGaA (Germany)

• QIAGEN (Netherlands)

• Beckman Coulter, Inc. (Danaher) (U.S.)

• QuidelOrtho Corporation (U.S.)